BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
94.95
-0.45 (-0.47%)
At close: Mar 28, 2025, 4:00 PM
94.00
-0.95 (-1.00%)
After-hours: Mar 28, 2025, 7:37 PM EDT
BioNTech SE Revenue
In the year 2024, BioNTech SE had annual revenue of 2.75B EUR, down -27.96%. BioNTech SE had revenue of 1.19B in the quarter ending December 31, 2024, a decrease of -19.54%.
Revenue (ttm)
2.75B EUR
Revenue Growth
-27.96%
P/S Ratio
8.01
Revenue / Employee
406,246 EUR
Employees
6,772
Market Cap
22.79B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.75B | -1.07B | -27.96% |
Dec 31, 2023 | 3.82B | -13.49B | -77.94% |
Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
BNTX News
- 15 hours ago - CureVac Shares Rise on Patent Confirmation Amid BioNTech Lawsuit - Market Watch
- 8 days ago - Refractory Metastatic Melanoma Pipeline Report 2025, with Focus on BioNTech SE, Y-mAbs and Therapeutics Seagen - GlobeNewsWire
- 11 days ago - BioNTech's Pivot Into Oncology Still Makes It A Compelling Investment - Seeking Alpha
- 18 days ago - BioNTech SE (BNTX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - BioNTech Stock Drops as Sales Outlook Disappoints - Investopedia
- 18 days ago - Pfizer's COVID-19 Shot Partner BioNTech Reports Q4 Profit, But 2025 Guidance Falls Short On Expectations - Benzinga
- 18 days ago - BioNTech guides for worse-than-expected 2025 revenue decline - Reuters
- 18 days ago - BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update - GlobeNewsWire